Reproductive Health Care via Telemedicine: Where does COVID-19 leave us?
Femtech, telehealth, and telemedicine have become essential to continuity of care for reproductive health during the COVID-19 global pandemic, projected to continue affecting our society well into 2021.
More specifically, telemedicine has allowed patients and practitioners to connect and to provide essential reproductive services, including fertility services, birth control, and even medical pregnancy termination in the privacy and convenience of one's home. This model is likely to continue to grow even after the pandemic has ended as there are clear benefits to both patients and healthcare practitioners alike.
How will insurance and healthcare systems evolve to accommodate this need? What is the future of reimbursements? Will health outcomes be improved or will this increase health disparities in vulnerable populations that live in digital poverty? These are some of the questions we'll answer at the Free CME Webinar Reproductive Health Care via Telemedicine: Where does COVID-19 leave us?